Fluor stock: new healthcare infrastructure mandate from Voyageur

Fluor (FLR) stock is in focus after Voyageur Pharmaceuticals engaged the company to run feasibility studies for two radiology contrast drug projects tied to Bayer backed iodine and barium manufacturing plans.

Fluor's latest healthcare infrastructure mandate comes after a strong run, with a 30 day share price return of 17.22% and a 5 year total shareholder return of 208.63%, suggesting momentum has been building around the stock.

If this kind of project pipeline catches your attention, it may be worth seeing what other infrastructure linked opportunities are out there through the 35 power grid technology and infrastructure stocks

Fluor’s shares have climbed sharply in recent weeks and now sit modestly above the average analyst price target. The key question is whether this healthcare contract pipeline leaves room for upside or if the market is already pricing in future growth.

Most popular Fluor narrative: 5.8% overvalued

Fluor last closed at $53.64 versus a most widely followed fair value estimate of $50.69, so the current price sits modestly above that narrative anchor.

Fluor's shift from revitalizing the capital structure to focusing on generating cash and earnings under its new strategy could drive earnings growth and improve net margins.

The strong backlog and significant new awards in life sciences, infrastructure, and key projects in Urban Solutions are expected to boost future revenue and earnings.

Curious how a relatively small shift in margins and revenue growth assumptions feeds into that $50.69 figure and a specific future P/E multiple, all discounted at 9.22%?

Result: Fair Value of $50.69 (OVERVALUED)

However, there are still pressure points, including project delays that affect revenue timing and margins, and foreign exchange swings that can chip away at Fluor’s earnings stability.

Another view of Fluor using market multiples

The SWS DCF model suggests Fluor is overvalued at $53.64 compared with an estimated future cash flow value of $18.09. Yet on P/E, the stock trades at 21.4x, well below the US Construction industry at 47.6x and an estimated fair ratio of 25.7x. Which signal do you put more weight on?

Next Steps

If you see both risks and rewards around Fluor and want to understand what matters most for you, act quickly by reviewing the full 2 key rewards and 2 important warning signs

Looking for more investment ideas beyond Fluor?

If Fluor has sharpened your focus on where capital is working hardest, do not stop here. Use the Simply Wall Street Screener to pressure test fresh ideas now.

• Hunt for quality at a discount by checking companies that line up in the 44 high quality undervalued stocks and see which ones match your return and risk preferences.
• Strengthen your income stream by reviewing stocks in the 8 dividend fortresses, focusing on businesses that pair higher yields with resilience.
• Prioritise resilience by scanning companies in the 71 resilient stocks with low risk scores that show lower risk scores and potentially steadier performance through different market conditions.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.